Skip to main content

NASDAQ:MEIP Investor Notice: Lawsuit Alleges Securities Laws Violations by MEI Pharma, Inc.

San Diego, CA -- (SBWIRE) -- 08/24/2020 -- An investor, who purchased NASDAQ:MEIP shares, filed a lawsuit against MEI Pharma, Inc. over alleged violations of Federal Securities Laws.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.